The patient with malignant lung cancer suffered from a rare complication in which the tumor secretes a protein that causes acute hypoglycemia. Israeli doctors used a breast cancer drug to treat it.
Ayan Barbora, who led the research, said nanotechnology has a significant role in developing a more-effective therapy for cancer.
In mouse model study, Weizmann Institute scientists test biomarker that could help doctors select lung cancer patients for treatment with a single antibody-based drug.
The drug in question, dubbed AOH1996, works by targeting the protein that helps facilitate cancer cells reproduce and spread throughout the body.
The researchers developed lipid-based nanoparticles – like those used in the COVID-19 vaccine – containing RNA molecules that silence the gene CKAP5.
The sugar was named after food from heaven that nourished ancient Israelis during their wandering in the desert.
The pilot project will continue with another flight for a young cancer patient from Israel’s southern Negev region in the coming weeks.
Even waiting until age 40 can be risky, as recent studies have shown high breast cancer mortality rates for women in that age group.
"Hair loss will gradually become a rare phenomenon during chemotherapy treatments," Dr. Larisa Rivo, Director of the Oncology Institute stated.
The Knesset Youth Committee discussed the fact that young people recovering from malignancies carry the effects of the disease for the rest of their lives.
JPOST Digital Library
